Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial

Hyman B. Muss,Mei-Yin Polley,Donald A. Berry,Heshan Liu,Constance T. Cirrincione,Maria Theodoulou,Ann M. Mauer,Alice B. Kornblith,Ann H. Partridge,Lynn G. Dressler,Harvey J. Cohen,Patricia A. Kartcheske,Edith A. Perez,Antonio C. Wolff,Julie R. Gralow,Harold J. Burstein,Ahmad A. Mahmood,Linda Sutton,Gustav Magrinat,Barbara A. Parker,Ronald D. Hart,Debjani Grenier,Arti Hurria,Aminah Jatoi,Larry Norton,Clifford A. Hudis,Eric P. Winer,Lisa A. Carey

Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial

2019

PURPOSEOlder women with breast cancer remain under-represented in clinical trials. The Cancer and Leukemia Group B 49907 trial focused on women age 65 years and older. We previously reported the pr...

Keywords:

Physical therapy
Leukemia
Capecitabine
Randomized controlled trial
Breast cancer
Clinical trial
Cancer
Adjuvant
Oncology
Medicine
Internal medicine
Chemotherapy
adjuvant chemotherapy
Group B

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations